Scotiabank Approved to Repurchase Up to 15 Million Common Shares
Summary
The Bank of Nova Scotia received approval for a new normal course issuer bid to repurchase up to 15 million common shares, representing approximately 1.2% of its outstanding shares, following the completion of its previous bid.
Key Events
-
New Share Repurchase Program Approved
Scotiabank received approval from the TSX and OSFI for a new normal course issuer bid to repurchase up to 15 million of its common shares.
-
Significant Capital Allocation
The new bid represents approximately 1.2% of the bank's 1,231,433,660 common shares outstanding as of March 24, 2026, valued at over $1 billion at current market prices.
-
Follows Completed Prior Bid
The new program commences on April 7, 2026, immediately after the bank fully utilized its existing bid, having repurchased all 20 million common shares for a total of $1.809 billion.
-
Strategic Purpose
The program aims to provide flexibility in managing the bank's capital position, offset options exercise dilution, and generate shareholder value, with all purchased shares to be cancelled.
Analysis
The Bank of Nova Scotia's approval for a new normal course issuer bid, allowing the repurchase of up to 15 million common shares, signals a continued commitment to returning capital to shareholders. This program, representing approximately 1.2% of outstanding shares and valued at over $1 billion, follows the full utilization of its previous bid. The consistent and immediate launch of a new repurchase program indicates management's confidence in the bank's financial position and its strategy to enhance shareholder value and manage dilution.
At the time of this filing, BNS was trading at $69.32 on NYSE in the Finance sector, with a market capitalization of approximately $86.5B. The 52-week trading range was $44.09 to $78.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.